Passage Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	41.58	49.34	60.06	30.11	6.95	0.93
Research & Development	61.42	86.05	117.67	81.79	29.74	9.17
Other Operating Expenses	-0.94	0.73	8	1	0.5	3.37
Operating Expenses	102.06	136.13	185.73	112.9	37.19	13.47
Operating Income	-102.06	-136.13	-185.73	-112.9	-37.19	-13.47
Other Expense / Income	-	-	-0.34	-0.67	8.45	-0.7
Pretax Income	-102.06	-136.13	-185.39	-112.23	-45.63	-12.77
Net Income	-102.06	-136.13	-185.39	-112.23	-45.63	-12.77
Shares Outstanding (Basic)	55	54	53	39	4	4
Shares Outstanding (Diluted)	55	54	53	39	4	4
Shares Change	0.58%	2.03%	38.14%	811.60%	17.74%	-
EPS (Basic)	-1.86	-2.50	-3.48	-2.91	-10.77	-3.55
EPS (Diluted)	-1.86	-2.50	-3.48	-2.91	-10.77	-3.55
Free Cash Flow	-78.41	-123.48	-152.52	-82.17	-41.09	-18.6
Free Cash Flow Per Share	-1.43	-2.27	-2.86	-2.13	-9.70	-5.17
EBITDA	-98.34	-132.45	-183.84	-111.43	-45.5	-12.77
Depreciation & Amortization	3.72	3.68	1.54	0.8	0.13	0
EBIT	-102.06	-136.13	-185.39	-112.23	-45.63	-12.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).